Is cholesterol and amyloid-β stress induced CD147 expression a protective response? evidence that extracellular cyclophilin a mediated neuroprotection is reliant on CD147

Journal of Alzheimer's Disease

Volumn 39, Issue 3, 2014, Pages 545-556

  Kanyenda, Limbikani J ^a,b,d   Verdile, Guiseppe ^a,c,d,e,f   Martins, Ralph ^a,c,d,e   Meloni, Bruno P ^a,b   Chieng, Joanne ^a   Mastaglia, Francis ^a   Laws, Simon M ^c,d,f   Anderton, Ryan S ^a   Boulos, Sherif ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

^d HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^e CURTIN UNIVERSITY   (Australia)

^f Curtin University ^*  (Australia)

Author keywords

Alzheimer's disease; A 42 ; CD147; cholesterol; cyclophilin A; neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CD147 ANTIGEN; CHOLESTEROL; CYCLOPHILIN A; HYDROGEN PEROXIDE; LACTATE DEHYDROGENASE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; AΒ$_{42}$; CD147; CHOLESTEROL; CYCLOPHILIN A; NEUROPROTECTION;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIGENS, CD147; CELLS, CULTURED; CEREBRAL CORTEX; CHOLESTEROL; CYCLOPHILIN A; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGEN PEROXIDE; L-LACTATE DEHYDROGENASE; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; TRANSDUCTION, GENETIC;

EID: 84894114736     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131442     Document Type: Article

References (83)

1. Sparks DL, Hunsaker JC 3rd, Scheff SW, Kryscio RJ, Henson JL, Markesbery WR (1990) Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 11, 601-607.
2. Sparks DL (1997) Coronary artery disease, hypertension, ApoE, and cholesterol: A link to Alzheimer's disease? Ann N Y Acad Sci 826, 128-146.
3. Martins IJ, Hone E, Foster JK, Sunram-Lea SI, Gnjec A, Fuller SJ, Nolan D, Gandy SE, Martins RN (2006) Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry 11, 721-736.
4. Sparks DL, Scheff SW, Hunsaker JC 3rd, Liu H, Landers T, Gross DR (1994) Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol 126, 88-94.
5. Sparks DL, Connor DJ, Browne PJ, Lopez JE, Sabbagh MN (2002) HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J Nutr Health Aging 6, 324-331.
6. Schmechel A, Strauss M, Schlicksupp A, Pipkorn R, Haass C, Bayer TA, Multhaup G (2004) Human BACE forms dimers and colocalizes with APP. J Biol Chem 279, 39710-39717.
7. Li YM, Lai MT, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK, Shi XP, Yin KC, Shafer JA, Gardell SJ (2000) Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 97, 6138-6143.
8. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD (2000) Correlation between elevated levelsof amyloid beta-peptidein the brain and cognitive decline. JAMA 283, 1571-1577.
9. Biswas J, Shanmugam MP, Gopal L (1995) Malignant melanoma of the choroid in association with oculodermal melanocytosis: A case report. Indian J Ophthalmol 43, 140-141.
10. Zhou S, Zhou H, Walian PJ, Jap BK (2005) CD147isa regulatory subunit of the gamma-secretase complex in Alzheimer's disease amyloid beta-peptide production. Proc Natl Acad Sci USA 102, 7499-7504.
11. Zhou S, Zhou H, Walian PJ, Jap BK (2007) Regulation of gamma-secretase activity in Alzheimer's disease. Biochemistry 46, 2553-2563.
12. Vetrivel KS, Zhang X, Meckler X, Cheng H, Lee S, Gong P, Lopes KO, Chen Y, Iwata N, Yin KJ, Lee JM, Parent AT, Saido TC, Li YM, Sisodia SS, Thinakaran G (2008) Evidence that CD147modulationofbeta-amyloid (Abeta) levelsismediated by extracellular degradation of secreted Abeta. J Biol Chem 283, 19489-19498.
13. Zhu P, Ding J, Zhou J, Dong WJ, Fan CM, Chen ZN (2005) Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: Its potential role in monocyte accumulation and matrix metalloproteinase production. Arthritis Res Ther 7, R1023-R1033.
14. Kanyenda LJ, Verdile G, Boulos S, Krishnaswamy S, Tad-dei K, Meloni BP, Mastaglia FL, Martins RN (2011) The dynamics of CD147 in Alzheimer's disease development and pathology. J Alzheimers Dis 26, 593-605.
15. Kataoka H, DeCastro R, Zucker S, Biswas C (1993) Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res 53, 3154-3158.
16. Guo H, Zucker S, Gordon MK, Toole BP, Biswas C (1997) Stimulationof matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J Biol Chem 272, 24-27.
17. Ko MH, Puglielli L (2007) The sterol carrier protein SCP-x/pro-SCP-2 gene has transcriptional activity and regulates the Alzheimer disease gamma-secretase. J Biol Chem 282, 19742-19752.
18. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap AP (2000) CD147 is tightly associated with lac-tate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J 19, 3896-3904.
19. Wilson MC, Meredith D, Fox JE, Manoharan C, Davies AJ, Halestrap AP (2005) Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: The ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem 280, 27213-27221.
20. Yurchenko V, Zybarth G, O'Connor M, Dai WW, Franchin G, Hao T, Guo H, Hung HC, Toole B, Gallay P, Sherry B, Bukrinsky M (2002) Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 277, 22959-22965.
21. Nahalkova J, Volkmann I, Aoki M, Winblad B, Bogdanovic N, Tjernberg LO, Behbahani H (2010) CD147, a gamma-secretase associated protein is upregulated in Alzheimer's disease brain and its cellular trafficking is affected by presenilin-2. Neurochem Int 56, 67-76.
22. Baum CL, Reschly EJ, Gayen AK, Groh ME, Schadick K (1997) Sterol carrier protein-2 overexpression enhances sterol cycling and inhibits cholesterol ester synthesis and high density lipoprotein cholesterol secretion. J Biol Chem 272, 6490-6498.
23. Zanlungo S, Amigo L, Mendoza H, Miquel JF, Vio C, Glick JM, Rodriguez A, Kozarsky K, Quinones V, Rigotti A, Nervi F (2000) Sterol carrier protein 2 gene transfer changes lipid metabolism and enterohepatic sterol circulation in mice. Gas-troenterology 119, 1708-1719.
24. Meloni BP, Majda BT, Knuckey NW (2001) Establishment of neuronal in vitro models of ischemia in 96-well microtiter strip-plates that result in acute, progressive and delayed neu-ronal death. Neuroscience 108, 17-26.
25. Kofron JL, Kuzmic P, Kishore V, Colon-Bonilla E, Rich DH (1991) Determination of kinetic constants for peptidyl pro-lyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 30, 6127-6134.
26. Boulos S, Meloni BP, Arthur PG, Bojarski C, Knuckey NW (2006) Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatoryelementinade-novirus vectors for transgene expression in cortical neuronal cultures. Brain Res 1102, 27-38.
27. Yao PM, Tabas I (2001) Free cholesterol loading of macrophages is associated with widespread mitochondrial dysfunction and activation of the mitochondrial apoptosis pathway. J Biol Chem 276, 42468-42476.
28. Matsuda A, Suzuki Y, Kondo K, Ikeda Y, Umemura K (2002) Hypercholesterolemia induces regressionin neointimal thickening due to apoptosis of vascular smooth muscle cells in the hamster endothelial injury model. Cardiovasc Res 53, 512-523.
29. Nilsson D, Sunnerhagen P (2011) Cellular stress induces cyto-plasmic RNA granules in fission yeast. RNA 17, 120-133.
30. Koponen J, Laakso K, Koskenniemi K, Kankainen M, Savi-joki K, Nyman TA, de Vos WM, Tynkkynen S, Kalkkinen N, Varmanen P (2012) Effect of acid stress on protein expression and phosphorylation in Lactobacillus rhamnosus GG. J Proteomics 75, 1357-1374.
31. Hara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K, Shenoy SK, Gregory SG, Ahn S, Duckett DR, Lefkowitz RJ (2011) A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477, 349-353.
32. Ying H, Furuya F, Willingham MC, Xu J, O'Malley BW, Cheng SY (2005) Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone. Mol Cell Biol 25, 7687-7695.
33. Salahudeen AK, Joshi M, Jenkins JK (2001) Apoptosis versus necrosis during cold storage and rewarming of human renal proximal tubular cells. Transplantation 72, 798-804.
34. Sawane MV, Kaore SB, Gaikwad RD, Patil PM, Patankar SS, Deshkar AM (2002) Seminal LDH-C4 isoenzyme and sperm mitochondrial activity: A study in male partners of infertile couples. Indian J Med Sci 56, 560-566.
35. Aras MA, Hartnett KA, Aizenman E (2008) Assessment of cell viability in primary neuronal cultures. Curr Protoc Neu-rosci Chapter 7, Unit 7 18.
36. Seko Y, Fujimura T, Taka H, Mineki R, Murayama K, Nagai R (2004) Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 317, 162-168.
37. Boulos S, Meloni BP, Arthur PG, Majda B, Bojarski C, Knuckey NW (2007) Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis 25, 54-64.
38. Trachtenberg A, Pushkarsky T, Heine S, Constant S, Brichacek B, Bukrinsky M (2011) The level of CD147 expression correlates with cyclophilin-induced signalling and chemotaxis. BMC Res Notes 4, 396.
39. Puglielli L, Rigotti A, Greco AV, Santos MJ, Nervi F (1995) Sterol carrier protein-2 is involved in cholesterol transfer from the endoplasmic reticulum to the plasma membrane in human fibroblasts. J Biol Chem 270, 18723-18726.
40. McLean MP, Puryear TK, Khan I, Azhar S, Billheimer JT, Orly J, Gibori G (1989) Estradiol regulation of sterol carrier protein-2 independent of cytochrome P450 side-chain cleavage expression in the rat corpus luteum. Endocrinology 125, 1337-1344.
41. Atshaves BP, Petrescu AD, Starodub O, Roths JB, Kier AB, Schroeder F (1999) Expression and intracellular processing of the 58kDa sterol carrier protein-2/3-oxoacyl-CoA thio-lase in transfected mouse L-cell fibroblasts. J Lipid Res 40, 610-622.
42. Atshaves BP, McIntosh AL, Martin GG, Landrock D, Payne HR, Bhuvanendran S, Landrock KK, Lyuksyutova OI, Johnson JD, Macfarlane RD, Kier AB, Schroeder F (2009) Overexpression of sterol carrier protein-2 differentially alters hepatic cholesterol accumulation in cholesterol-fed mice. J Lipid Res 50, 1429-1447.
43. Moncecchi D, Murphy EJ, Prows DR, Schroeder F (1996) Sterol carrier protein-2 expression in mouse L-cell fibroblasts alters cholesterol uptake. Biochim Biophys Acta 1302, 110-116.
44. Kraemer R, Pomerantz KB, Kesav S, Scallen TJ, Hajjar DP (1995) Cholesterol enrichment enhances expression of sterol-carrier protein-2: Implications for its function in intracellular cholesterol trafficking. J Lipid Res 36, 2630-2638.
45. Nixon RA (2004) Niemann-Pick Type C disease and Alzheimer's disease: The APP-endosome connection fattens up. Am J Pathol 164, 757-761.
46. Murphy EJ, Schroeder F (1997) Sterol carrier protein-2 mediated cholesterol esterification in transfected L-cell fibroblasts. Biochim Biophys Acta 1345, 283-292.
47. Zhou M, Parr RD, Petrescu AD, Payne HR, Atshaves BP, Kier AB, Ball JM, Schroeder F (2004) Sterol carrier protein-2 directly interacts with caveolin-1 in vitro and in vivo. Biochemistry 43, 7288-7306.
48. Hailstones D, Sleer LS, Parton RG, Stanley KK (1998) Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 39, 369-379.
49. Jia L, Wang S, Zhou H, Cao J, Hu Y, Zhang J (2006) Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines. Int J Biochem Cell Biol 38, 1584-1593.
50. Cutler RG, Pedersen WA, Camandola S, Rothstein JD, Matt-son MP (2002) Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann Neurol 52, 448-457.
51. Metrailler-Ruchonnet I, Pagano A, Carnesecchi S, Khatib K, Herrera P, Donati Y, Bron C, Barazzone C (2010) Bcl-2 overexpression in type II epithelial cells does not prevent hyperoxia-induced acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol 299, L312-L322.
52. Feng X, Xia Q, Yuan L, Yang X, Wang K (2010) Impaired mitochondrial function and oxidative stress in rat cortical neurons: Implications for gadolinium-induced neurotoxicity. Neurotoxicology 31, 391-398.
53. Zhang L, Yu H, Zhao X, Lin X, Tan C, Cao G, Wang Z (2010) Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells. Neurochem Int 57, 547-555.
54. Wu C, Zhou D, Wen C, Zhang L, Como P, Qiao Y (2003) Relationship between blood pressure and Alzheimer's disease in Linxian County, China. Life Sci 72, 1125-1133.
55. Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA (2000) Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7, 321-331.
56. Fitz NF, Cronican A, Pham T, Fogg A, Fauq AH, Chapman R, Lefterov I, Koldamova R (2010) Liver X receptor agonist treatment ameliorates amyloid pathology andmemory deficits caused by high-fat diet in APP23 mice. J Neurosci 30, 6862-6872.
57. Lin H, Bhatia R, Lal R (2001) Amyloid beta protein forms ion channels: Implications for Alzheimer's disease pathophysiol-ogy. FASEB J 15, 2433-2444.
58. Smith DH, Nakamura M, McIntosh TK, Wang J, Rodriguez A, Chen XH, Raghupathi R, Saatman KE, Clemens J, Schmidt ML, Lee VM, Trojanowski JQ (1998) Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein. Am J Pathol 153, 1005-1010.
59. Butterfield DA, Castegna A, Lauderback CM, Drake J (2002) Evidence that amyloid beta-peptide-induced lipid peroxida-tion and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-664.
60. Galbete JL, Martin TR, Peressini E, Modena P, Bianchi R, Forloni G (2000) Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glyco-sylation in the protein secretory pathway. Biochem J 348 Pt 2, 307-313.
61. Lu X, Liu J, Hou F, Liu Z, Cao X, Seo H, Gao B (2011) Cholesterol induces pancreatic beta cell apoptosis through oxidative stress pathway.Cell Stress Chaperones16, 539-548.
62. Oliveros LB, Videla AM, Gimenez MS (2004) Effect of dietary fat saturation on lipid metabolism, arachidonic acid turnover and peritoneal macrophage oxidative stress in mice. Braz J Med Biol Res 37, 311-320.
63. Mei S, Gu H, Yang X, Guo H, Liu Z, Cao W (2012) Prolonged exposure to insulin induces mitochondrion-derived oxidative stress through increasing mitochondrial cholesterol content in hepatocytes. Endocrinology 153, 2120-2129.
64. Homma Y, Kondo Y, Kaneko M, Kitamura T, Nyou WT, Yanagisawa M, Yamamoto Y, Kakizoe T (2004) Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Carcinogenesis 25, 1011-1014.
65. Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q, Zhang H, Yang H, Chen Z, Xing J (2012) Hypoxia upregulates CD147 through a combined effect of HIF-1alpha and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis 33, 1598-1607.
66. Zhu W, Khachi S, Hao Q, Shen F, Young WL, Yang GY, Chen Y (2008) Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem Int 52, 1086-1091.
67. Redell JB, Zhao J, Dash PK (2007) Acutely increased cyclophilin a expression after brain injury: A role in blood-brain barrier function and tissue preservation. J Neurosci Res 85, 1980-1988.
68. Tribouillard-Tanvier D, Carroll JA, Moore RA, Striebel JF, Chesebro B (2012) Roleofcyclophilin A from brainsofprion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro. J Biol Chem 287, 4628-4639.
69. Saratsis AM, Yadavilli S, Magge S, Rood BR, Perez J, Hill DA, Hwang E, Kilburn L, Packer RJ, Nazarian J (2012) Insights into pediatric diffuse intrinsic pontine glioma through proteomic analysis of cerebrospinal fluid. Neuro Oncol 14, 547-560.
70. Ge YS, Teng WY, Zhang CD (2009) Protective effect of cyclophilin A against Alzheimer's amyloid beta-peptide (25-35)-induced oxidative stress in PC12 cells. Chin Med J (Engl) 122, 716-724.
71. Yang F, Chen X, Su J (2008) [The role of CD147 in the proliferation, activation and chemotaxis of Jurkat cell induced by cyclophilin A]. Zhonghua Xue Ye Xue Za Zhi 29, 793-796.
72. Perkins D, Pereira EF, Aurelian L (2003) The herpes simplex virus type2 R1 protein kinase (ICP10 PK) functionsas a dominant regulatorofapoptosisinhippocampal neurons involving activation of the ERK survival pathway and upregulation of the antiapoptotic protein Bag-1. J Virol 77, 1292-1305.
73. Biswas SC, Greene LA (2002) Nerve growth factor (NGF) down-regulates the Bcl-2 homology 3 (BH3) domain-only protein Bim and suppresses its proapoptotic activity by phos-phorylation. J Biol Chem 277, 49511-49516.
74. Abdi A, Sadraie H, Dargahi L, Khalaj L, Ahmadiani A (2011) Apoptosis inhibition can be threatening in Abeta-induced neuroinflammation, through promoting cell proliferation. Neurochem Res 36, 39-48.
75. Seizer P, Schonberger T, Schott M, Lang MR, Langer HF, Bigalke B, Kramer BF, Borst O, Daub K, Heidenreich O, Schmidt R, Lindemann S, Herouy Y, Gawaz M, May AE (2010) EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation. Atherosclerosis 209, 51-57.
76. Yang Y, Lu N, Zhou J, Chen ZN, Zhu P (2008) Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 47, 1299-1310.
77. Bahmed K, Henry C, Holliday M, Redzic J, Ciobanu M, Zhang F, Weekes C, Sclafani R, Degregori J, Eisenmesser E (2012) Extracellular cyclophilin-A stimulates ERK1/2 phos-phorylationin a cell-dependent manner but broadly stimulates nuclear factor kappa B. Cancer Cell Int 12, 19.
78. Backstrom JR, Lim GP, Cullen MJ, Tokes ZA (1996) Matrix metalloproteinase-9 (MMP-9) issynthesizedinneurons of the human hippocampus and is capable ofdegrading the amyloid-beta peptide (1-40). J Neurosci 16, 7910-7919.
79. Bruno MA, Mufson EJ, Wuu J, Cuello AC (2009) Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 68, 1309-1318.
80. Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF (2003) Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 43, 191-196.
81. Romi F, Helgeland G, Gilhus NE (2012) Serum levels of matrix metalloproteinases: Implications in clinical neurology. Eur Neurol 67, 121-128.
82. Nalivaeva NN, Fisk LR, Belyaev ND, Turner AJ (2008) Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 5, 212-224.
83. Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascu-lar integrity via cyclophilin A. Nature 485, 512-516.